Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
job ratings (see below graph) for JNJ
job ratings for JNJ
11/16/23
industry:
Big Pharma
company:
JNJ
job rating:
6
Boss is supportive and gives FTO
12/06/18
industry:
Medical Device
job title:
Staff engineer
company:
JNJ
job rating:
3
Compliance rules make no sense, no pragmatism, rules other commintment in multiple policy. Creating gap and auto-feeding compliant and audit department. It is like if there is not pilot in the plane.
07/25/18
industry:
Medical Device
company:
JNJ
job rating:
1
over worked and under paid
latest headlines for company on cafepharma
J&J joins Pfizer in detailing impact of Part D redesign
BioPharma Dive
Wed, 01/22/25 - 07:23 pm
Tags:
JNJ
,
Pfizer
,
Medicare Part D
J&J oncology sales grow, but shares slide on outlook
BioPharma Dive
Wed, 01/22/25 - 12:01 pm
Tags:
JNJ
,
earnings
,
oncology
,
Multiple Myeloma
JPM25 Recap: The Medtech Moments That Have the Industry Buzzing
Medical Devices and Diagnostics Industry
Tue, 01/21/25 - 07:10 pm
Tags:
Medtech
,
JPMHC 2025
,
Illumina
,
PFA
,
JNJ
,
Medtronic
,
Boston Scientific
,
CGMs
,
Intuitive Surgical
,
robotic surgery
,
Embecta
,
renal denervation
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
CNBC
Tue, 01/21/25 - 11:34 am
Tags:
JNJ
,
FDA
,
major depressive disorder
,
Spravato
,
ketamine
EU approves endometrial, lung cancer drugs from GSK and J&J
Pharmaphorum
Tue, 01/21/25 - 11:10 am
Tags:
Eurioe
,
GSK
,
JNJ
,
endometrial cancer
,
lung cancer
,
Jemperli
,
Rybrevant
,
Lazcluze
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thu, 01/16/25 - 11:02 am
Tags:
JPMHC 2025
,
M&A
,
JNJ
,
Intra-Cellular Therapeutics
,
GSK
,
IDRx
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Mon, 01/13/25 - 11:19 am
Tags:
JNJ
,
Intra-Cellular Therapies
,
JPMHC 2025
,
M&A
,
psychiatric disease
Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex
Fierce Pharma
Thu, 01/9/25 - 11:55 am
Tags:
JNJ
,
Darzalex
,
Sanofi
,
Sarclisa
,
Multiple Myeloma
J&J Halts PFA Cases Amid Stroke Reports
Medical Devices and Diagnostics Industry
Wed, 01/8/25 - 11:18 pm
Tags:
Medtech
,
JNJ
,
Varipulse
,
stroke
,
pulse field ablation
J&J says its lung cancer drug combination keeps people alive longer
CNBC
Tue, 01/7/25 - 11:13 am
Tags:
JNJ
,
Rybrevant
,
Lazcluze
,
AstraZeneca
,
Tagrisso
,
clinical trials
,
lung cancer
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Fierce Biotech
Mon, 01/6/25 - 10:58 am
Tags:
layoffs
,
biotech
,
Pfizer
,
JNJ
,
Bristol Myers Squibb
,
Roivant
How pharma was instrumental in President Jimmy Carter’s global health efforts
Pharma Voice
Fri, 01/3/25 - 09:57 am
Tags:
Jimmy Carter
,
Merck
,
GSK
,
JNJ
,
Amgen
6 Critical Developments That Could Define the Medical Device Industry in 2025
Medical Devices and Diagnostics Industry
Thu, 01/2/25 - 11:20 am
Tags:
devices
,
Medtech
,
Europe
,
Medtronic
,
Abbott Labs
,
CGMs
,
JNJ
,
robotic surgery
,
Donald Trump
,
M&A
PFA to surpass radiofrequency ablation in 2025: Citi survey
Medtech Dive
Tue, 12/17/24 - 12:01 pm
Tags:
Medtech
,
pulsed field ablation
,
radiofrequency ablation
,
Medtronic
,
Boston Scientific
,
JNJ
FDA dents J&J's blockbuster hopes for Rybrevant
Pharmaphorum
Tue, 12/17/24 - 11:53 am
Tags:
JNJ
,
Rybrevant
,
FDA
ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases
Fierce Pharma
Thu, 12/12/24 - 11:44 pm
Tags:
ICER
,
drug pricing
,
Gilead Sciences
,
JNJ
,
Novartis
Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti
BioSpace
Tue, 12/10/24 - 11:41 am
Tags:
Gilead Sciences
,
Arcellx
,
anito-cel
,
JNJ
,
Carvykti
,
Multiple Myeloma
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
Fierce Pharma
Mon, 12/9/24 - 09:10 pm
Tags:
ASH 2024
,
GSK
,
Blenrep
,
JNJ
,
Darzalex
,
Multiple Myeloma
Johnson and Johnson Submits FDA Request for Pediatric Tremfya Approval
Managed Healthcare Executive
Mon, 12/2/24 - 07:17 pm
Tags:
JNJ
,
Tremfya
,
pediatric
,
psoriasis
,
juvenile psoriatic arthritis
As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK
Fierce Pharma
Fri, 11/22/24 - 11:51 am
Tags:
JNJ
,
legal
,
UK
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.